Guru Ownership Trend
Guru Analysis for Cartesian Therapeutics, Inc. (RNAC)
Cartesian Therapeutics, Inc. (RNAC), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.25 M.
Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $433,647 net inflow during the quarter.
Recent activity highlights Cliff Asness who opened a new position.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Cartesian Therapeutics, Inc. (RNAC)
Major holders include Cliff Asness ($516,724), Renaissance Technologies (RenTech) ($413,895). According to the latest reported data, 2 tracked investment managers collectively hold approximately 151,320 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $433,647, with 2 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 0 managers trimmed their positions, while 1 fully exited RNAC. The total reported sell value was $244,207.
Yes, 1 managers opened new positions in RNAC, and 1 increased their existing holdings. The total reported buy value was $677,854.